Haleos Labs Ltd.
•₹ 1,4650.62%
2026-08-21
PROS
- Company has consistently been profitable over the last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.00x)
- Working capital cycle has improved - days down from 12 to 8
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of 6.9% over last 3 years
- Company has a low return on capital employed of 9.8%
- Company has delivered a poor sales growth of 5.7% over past five years
- Growth is decelerating - 3Y profit CAGR (-9.5%) trails the 5Y trend (13.0%)
- Though reporting repeated profits, the company pays out little dividend (2.3%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | HALEOSLABS | 1456.40 | 27.86 | 440.31 | 0.10 | 18.40 | 319.90 | 729.42 | 784.09 | 12.60 | 12.50 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75 | 69 | 72 | 90 | 93 | 78 | 85 | 89 | 83 | 81 | 95 | 75 | 73 | |
| 72 | 61 | 63 | 79 | 76 | 70 | 72 | 82 | 71 | 68 | 81 | 71 | 70 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 0 | 1 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 0 | 2 | 0 |
| Interest | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| -3 | 2 | 4 | 7 | 11 | 5 | 7 | 4 | 7 | 8 | 9 | 1 | 3 | |
| Tax % | -40.29% | 126.51% | -8.14% | 8.87% | 33.27% | 29.79% | 29.77% | 11.45% | 37.61% | 24.38% | 24.26% | 61.54% | 46.48% |
| Net Profit | 0 | 0 | 0 | 0 | 7 | 3 | 5 | 3 | 4 | 6 | 7 | 0 | 2 |
| -6 | 2 | 14 | 20 | 23 | 15 | 18 | 10 | 14 | 20 | 22 | 1 | 1 | |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 75
- 72
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- -3
- Tax %
- -40.29%
- Net Profit
- 0
- -6
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 69
- 61
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 4
- 2
- Tax %
- 126.51%
- Net Profit
- 0
- 2
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 72
- 63
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- 4
- Tax %
- -8.14%
- Net Profit
- 0
- 14
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 90
- 79
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 3
- Depreciation
- 4
- 7
- Tax %
- 8.87%
- Net Profit
- 0
- 20
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 93
- 76
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 11
- Tax %
- 33.27%
- Net Profit
- 7
- 23
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 78
- 70
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 4
- 5
- Tax %
- 29.79%
- Net Profit
- 3
- 15
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 85
- 72
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 7
- Tax %
- 29.77%
- Net Profit
- 5
- 18
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 89
- 82
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 4
- 4
- Tax %
- 11.45%
- Net Profit
- 3
- 10
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 83
- 71
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- 7
- Tax %
- 37.61%
- Net Profit
- 4
- 14
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 81
- 68
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 8
- Tax %
- 24.38%
- Net Profit
- 6
- 20
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 95
- 81
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 9
- Tax %
- 24.26%
- Net Profit
- 7
- 22
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 75
- 71
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 4
- 1
- Tax %
- 61.54%
- Net Profit
- 0
- 1
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 73
- 70
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 3
- Tax %
- 46.48%
- Net Profit
- 2
- 1
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 3
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 378 | 261 | 266 | 350 | 316 | 306 | 345 | 324 | |
| 343 | 235 | 235 | 316 | 287 | 275 | 300 | 289 | |
| Operating Profit | 37 | 28 | 32 | 36 | 32 | 35 | 50 | — |
| OPM % | 10 | 11 | 12 | 10 | 10 | 11 | 14 | — |
| Other Income | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 3 |
| Interest | 6 | 5 | 5 | 6 | 7 | 10 | 9 | 6 |
| Depreciation | 6 | 8 | 8 | 10 | 11 | 15 | 15 | 16 |
| 25 | 15 | 20 | 33 | 17 | 10 | 26 | 22 | |
| Tax % | 30 | 31 | 31 | 23 | 31 | 36 | 28 | 29 |
| Net Profit | 18 | 10 | 14 | 25 | 11 | 6 | 19 | 15 |
| EPS | 59 | 34 | 45 | 84 | 38 | 30 | 67 | — |
| Dividend Payout % | 3 | 0 | 3 | 2 | 4 | 5 | 2 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 3 | 1 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 59 | 34 | 45 | 84 | 38 | 30 | 67 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 3 | 1 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 59 | 34 | 45 | 84 | 38 | 30 | 67 | — |
Mar 2019
- 378
- 343
- Operating Profit
- 37
- OPM %
- 10
- Other Income
- 3
- Interest
- 6
- Depreciation
- 6
- 25
- Tax %
- 30
- Net Profit
- 18
- EPS
- 59
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 59
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 59
Mar 2020
- 261
- 235
- Operating Profit
- 28
- OPM %
- 11
- Other Income
- 2
- Interest
- 5
- Depreciation
- 8
- 15
- Tax %
- 31
- Net Profit
- 10
- EPS
- 34
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 34
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 34
Mar 2021
- 266
- 235
- Operating Profit
- 32
- OPM %
- 12
- Other Income
- 2
- Interest
- 5
- Depreciation
- 8
- 20
- Tax %
- 31
- Net Profit
- 14
- EPS
- 45
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 45
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 45
Mar 2022
- 350
- 316
- Operating Profit
- 36
- OPM %
- 10
- Other Income
- 2
- Interest
- 6
- Depreciation
- 10
- 33
- Tax %
- 23
- Net Profit
- 25
- EPS
- 84
- Dividend Payout %
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 84
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 84
Mar 2023
- 316
- 287
- Operating Profit
- 32
- OPM %
- 10
- Other Income
- 3
- Interest
- 7
- Depreciation
- 11
- 17
- Tax %
- 31
- Net Profit
- 11
- EPS
- 38
- Dividend Payout %
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 38
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 38
Mar 2024
- 306
- 275
- Operating Profit
- 35
- OPM %
- 11
- Other Income
- 4
- Interest
- 10
- Depreciation
- 15
- 10
- Tax %
- 36
- Net Profit
- 6
- EPS
- 30
- Dividend Payout %
- 5
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 30
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 30
Mar 2025
- 345
- 300
- Operating Profit
- 50
- OPM %
- 14
- Other Income
- 5
- Interest
- 9
- Depreciation
- 15
- 26
- Tax %
- 28
- Net Profit
- 19
- EPS
- 67
- Dividend Payout %
- 2
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 67
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 67
TTM
- 324
- 289
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 6
- Depreciation
- 16
- 22
- Tax %
- 29
- Net Profit
- 15
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 6%
- 3 Years:
- -1%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 15%
- 3 Years:
- -7%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 10%
- 3 Years:
- 7%
- Last Year:
- 10%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 103 | 113 | 126 | 149 | 166 | 174 | 194 | |
| 19 | 27 | 25 | 37 | 44 | 47 | 50 | |
| Trade Payables | 98 | 49 | 67 | 78 | 60 | 59 | 53 |
| 53 | 65 | 86 | 97 | 126 | 112 | 99 | |
| Total Liabilities | 276 | 256 | 307 | 364 | 398 | 395 | 399 |
| ASSETS | - | - | - | - | - | - | - |
| 117 | 124 | 130 | 142 | 228 | 223 | 232 | |
| Capital Work in Progress | 3 | 16 | 38 | 51 | 1 | 6 | 0 |
| 81 | 64 | 62 | 85 | 86 | 81 | 67 | |
| 0 | 0 | 0 | 0 | 0 | 51 | 69 | |
| Cash & Bank | 3 | 8 | 11 | 4 | 4 | 1 | 2 |
| 72 | 44 | 66 | 82 | 78 | 31 | 29 | |
| Total Assets | 276 | 256 | 307 | 364 | 398 | 395 | 399 |
| Total Debt | 47 | 64 | 64 | 77 | 99 | 98 | 84 |
| Net Working Capital | 17 | 20 | 12 | 21 | 26 | 11 | 9 |
| Contingent Liabilities | 4 | 5 | 7 | 5 | 5 | 18 | 19 |
| Book Value per Share | 351.70 | 382.80 | 427.40 | 503.53 | 557.71 | 584.84 | 650.15 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 47 | 64 | 64 | 77 | 99 | 98 | 84 |
| Net Working Capital | 17 | 20 | 12 | 21 | 26 | 11 | 9 |
| Contingent Liabilities | 4 | 5 | 7 | 5 | 5 | 18 | 19 |
| Book Value per Share | 351.70 | 382.80 | 427.40 | 503.53 | 557.71 | 584.84 | 650.15 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2019
- Equity Capital
- 3
- 103
- 19
- Trade Payables
- 98
- 53
- Total Liabilities
- 276
- 117
- Capital Work in Progress
- 3
- 81
- 0
- Cash & Bank
- 3
- 72
- Total Assets
- 276
- Total Debt
- 47
- Net Working Capital
- 17
- Contingent Liabilities
- 4
- Book Value per Share
- 351.70
- Face Value
- 10.00
- Total Debt
- 47
- Net Working Capital
- 17
- Contingent Liabilities
- 4
- Book Value per Share
- 351.70
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 3
- 113
- 27
- Trade Payables
- 49
- 65
- Total Liabilities
- 256
- 124
- Capital Work in Progress
- 16
- 64
- 0
- Cash & Bank
- 8
- 44
- Total Assets
- 256
- Total Debt
- 64
- Net Working Capital
- 20
- Contingent Liabilities
- 5
- Book Value per Share
- 382.80
- Face Value
- 10.00
- Total Debt
- 64
- Net Working Capital
- 20
- Contingent Liabilities
- 5
- Book Value per Share
- 382.80
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 3
- 126
- 25
- Trade Payables
- 67
- 86
- Total Liabilities
- 307
- 130
- Capital Work in Progress
- 38
- 62
- 0
- Cash & Bank
- 11
- 66
- Total Assets
- 307
- Total Debt
- 64
- Net Working Capital
- 12
- Contingent Liabilities
- 7
- Book Value per Share
- 427.40
- Face Value
- 10.00
- Total Debt
- 64
- Net Working Capital
- 12
- Contingent Liabilities
- 7
- Book Value per Share
- 427.40
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 3
- 149
- 37
- Trade Payables
- 78
- 97
- Total Liabilities
- 364
- 142
- Capital Work in Progress
- 51
- 85
- 0
- Cash & Bank
- 4
- 82
- Total Assets
- 364
- Total Debt
- 77
- Net Working Capital
- 21
- Contingent Liabilities
- 5
- Book Value per Share
- 503.53
- Face Value
- 10.00
- Total Debt
- 77
- Net Working Capital
- 21
- Contingent Liabilities
- 5
- Book Value per Share
- 503.53
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 3
- 166
- 44
- Trade Payables
- 60
- 126
- Total Liabilities
- 398
- 228
- Capital Work in Progress
- 1
- 86
- 0
- Cash & Bank
- 4
- 78
- Total Assets
- 398
- Total Debt
- 99
- Net Working Capital
- 26
- Contingent Liabilities
- 5
- Book Value per Share
- 557.71
- Face Value
- 10.00
- Total Debt
- 99
- Net Working Capital
- 26
- Contingent Liabilities
- 5
- Book Value per Share
- 557.71
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 3
- 174
- 47
- Trade Payables
- 59
- 112
- Total Liabilities
- 395
- 223
- Capital Work in Progress
- 6
- 81
- 51
- Cash & Bank
- 1
- 31
- Total Assets
- 395
- Total Debt
- 98
- Net Working Capital
- 11
- Contingent Liabilities
- 18
- Book Value per Share
- 584.84
- Face Value
- 10.00
- Total Debt
- 98
- Net Working Capital
- 11
- Contingent Liabilities
- 18
- Book Value per Share
- 584.84
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 3
- 194
- 50
- Trade Payables
- 53
- 99
- Total Liabilities
- 399
- 232
- Capital Work in Progress
- 0
- 67
- 69
- Cash & Bank
- 2
- 29
- Total Assets
- 399
- Total Debt
- 84
- Net Working Capital
- 9
- Contingent Liabilities
- 19
- Book Value per Share
- 650.15
- Face Value
- 10.00
- Total Debt
- 84
- Net Working Capital
- 9
- Contingent Liabilities
- 19
- Book Value per Share
- 650.15
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 30 | 15 | 35 | -11 | 15 | 24 | 34 | |
| Cash from Investing | -44 | -27 | -26 | -7 | -31 | -18 | -15 |
| Cash from Financing | 15 | 12 | -3 | 11 | 17 | -7 | -19 |
| 1 | -0 | 6 | -8 | 0 | -1 | -0 | |
| Free Cash Flow | 30 | -12 | -2 | -37 | -38 | 10 | 17 |
| OCF / Net Profit | 1.68 | 1.43 | 2.59 | -0.44 | 1.29 | 3.84 | 1.82 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -79 | -50 |
| OCF / Net Profit | 1.68 | 1.43 | 2.59 | -0.44 | 1.29 | 3.84 | 1.82 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -79 | -50 |
Mar 2019
- 30
- Cash from Investing
- -44
- Cash from Financing
- 15
- 1
- Free Cash Flow
- 30
- OCF / Net Profit
- 1.68
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.68
- Cumulative 5-Year FCF
- 0
Mar 2020
- 15
- Cash from Investing
- -27
- Cash from Financing
- 12
- -0
- Free Cash Flow
- -12
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- 0
Mar 2021
- 35
- Cash from Investing
- -26
- Cash from Financing
- -3
- 6
- Free Cash Flow
- -2
- OCF / Net Profit
- 2.59
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.59
- Cumulative 5-Year FCF
- 0
Mar 2022
- -11
- Cash from Investing
- -7
- Cash from Financing
- 11
- -8
- Free Cash Flow
- -37
- OCF / Net Profit
- -0.44
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.44
- Cumulative 5-Year FCF
- 0
Mar 2023
- 15
- Cash from Investing
- -31
- Cash from Financing
- 17
- 0
- Free Cash Flow
- -38
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
Mar 2024
- 24
- Cash from Investing
- -18
- Cash from Financing
- -7
- -1
- Free Cash Flow
- 10
- OCF / Net Profit
- 3.84
- Cumulative 5-Year FCF
- -79
- OCF / Net Profit
- 3.84
- Cumulative 5-Year FCF
- -79
Mar 2025
- 34
- Cash from Investing
- -15
- Cash from Financing
- -19
- -0
- Free Cash Flow
- 17
- OCF / Net Profit
- 1.82
- Cumulative 5-Year FCF
- -50
- OCF / Net Profit
- 1.82
- Cumulative 5-Year FCF
- -50
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 59.03 | 33.68 | 44.84 | 83.76 | 37.91 | 30.08 | 66.51 |
| Book Value (₹) | 351.70 | 382.80 | 427.40 | 503.53 | 557.71 | 584.84 | 650.15 |
| Dividend per Share (₹) | 1.50 | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Cash EPS (₹) | 80.14 | 59.69 | 70.84 | 116.78 | 73.32 | 70.34 | 111.56 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 8.95% | 9.53% | 10.85% | 9.33% | 8.91% | 9.21% | 11.68% |
| Net Margin % | 4.29% | 3.51% | 4.59% | 6.51% | 3.18% | 1.87% | 4.85% |
| ROE % | 16.78% | 9.17% | 11.07% | 17.98% | 7.09% | 3.66% | 10.03% |
| ROCE % | 20.14% | 11.91% | 12.96% | 18.42% | 9.44% | 7.42% | 12.60% |
| 6.45% | 3.83% | 4.82% | 7.54% | 2.98% | 1.60% | 4.72% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 36 | 40 | 34 | 32 | 41 | 52 | 57 |
| Inventory Days | 71 | 91 | 78 | 69 | 87 | 90 | 70 |
| Payable Days | 140 | 170 | 155 | 136 | 146 | 143 | 133 |
| -32 | -39 | -42 | -35 | -19 | -1 | -6 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.44x | 0.55x | 0.50x | 0.51x | 0.58x | 0.55x | 0.43x |
| Interest Coverage (x) | 5.61x | 3.85x | 5.26x | 6.26x | 3.42x | 1.96x | 3.99x |
| 1.13x | 1.22x | 1.10x | 1.14x | 1.19x | 1.07x | 1.06x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | -30.98% | 1.84% | 31.81% | -9.86% | -3.04% | 12.67% |
| Operating Profit Growth % | 0.00% | -25.74% | 15.71% | 13.25% | -12.07% | 9.88% | 42.54% |
| Net Profit Growth % | 0.00% | -42.94% | 33.13% | 86.62% | -55.03% | -44.38% | 196.03% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -20.68% | 121.15% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 22.57x | 16.24x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.16x | 1.66x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.22% | 0.14% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 8.60x | 8.19x |
Mar 2019
- EPS (₹)
- 59.03
- Book Value (₹)
- 351.70
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 80.14
- Operating Margin %
- 8.95%
- Net Margin %
- 4.29%
- ROE %
- 16.78%
- ROCE %
- 20.14%
- 6.45%
- Debtor Days
- 36
- Inventory Days
- 71
- Payable Days
- 140
- -32
- Debt to Equity (x)
- 0.44x
- Interest Coverage (x)
- 5.61x
- 1.13x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 33.68
- Book Value (₹)
- 382.80
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 59.69
- Operating Margin %
- 9.53%
- Net Margin %
- 3.51%
- ROE %
- 9.17%
- ROCE %
- 11.91%
- 3.83%
- Debtor Days
- 40
- Inventory Days
- 91
- Payable Days
- 170
- -39
- Debt to Equity (x)
- 0.55x
- Interest Coverage (x)
- 3.85x
- 1.22x
- Revenue Growth %
- -30.98%
- Operating Profit Growth %
- -25.74%
- Net Profit Growth %
- -42.94%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 44.84
- Book Value (₹)
- 427.40
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 70.84
- Operating Margin %
- 10.85%
- Net Margin %
- 4.59%
- ROE %
- 11.07%
- ROCE %
- 12.96%
- 4.82%
- Debtor Days
- 34
- Inventory Days
- 78
- Payable Days
- 155
- -42
- Debt to Equity (x)
- 0.50x
- Interest Coverage (x)
- 5.26x
- 1.10x
- Revenue Growth %
- 1.84%
- Operating Profit Growth %
- 15.71%
- Net Profit Growth %
- 33.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 83.76
- Book Value (₹)
- 503.53
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 116.78
- Operating Margin %
- 9.33%
- Net Margin %
- 6.51%
- ROE %
- 17.98%
- ROCE %
- 18.42%
- 7.54%
- Debtor Days
- 32
- Inventory Days
- 69
- Payable Days
- 136
- -35
- Debt to Equity (x)
- 0.51x
- Interest Coverage (x)
- 6.26x
- 1.14x
- Revenue Growth %
- 31.81%
- Operating Profit Growth %
- 13.25%
- Net Profit Growth %
- 86.62%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 37.91
- Book Value (₹)
- 557.71
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 73.32
- Operating Margin %
- 8.91%
- Net Margin %
- 3.18%
- ROE %
- 7.09%
- ROCE %
- 9.44%
- 2.98%
- Debtor Days
- 41
- Inventory Days
- 87
- Payable Days
- 146
- -19
- Debt to Equity (x)
- 0.58x
- Interest Coverage (x)
- 3.42x
- 1.19x
- Revenue Growth %
- -9.86%
- Operating Profit Growth %
- -12.07%
- Net Profit Growth %
- -55.03%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 30.08
- Book Value (₹)
- 584.84
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 70.34
- Operating Margin %
- 9.21%
- Net Margin %
- 1.87%
- ROE %
- 3.66%
- ROCE %
- 7.42%
- 1.60%
- Debtor Days
- 52
- Inventory Days
- 90
- Payable Days
- 143
- -1
- Debt to Equity (x)
- 0.55x
- Interest Coverage (x)
- 1.96x
- 1.07x
- Revenue Growth %
- -3.04%
- Operating Profit Growth %
- 9.88%
- Net Profit Growth %
- -44.38%
- -20.68%
- P/E (x)
- 22.57x
- P/B (x)
- 1.16x
- Dividend Yield %
- 0.22%
- 8.60x
Mar 2025
- EPS (₹)
- 66.51
- Book Value (₹)
- 650.15
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 111.56
- Operating Margin %
- 11.68%
- Net Margin %
- 4.85%
- ROE %
- 10.03%
- ROCE %
- 12.60%
- 4.72%
- Debtor Days
- 57
- Inventory Days
- 70
- Payable Days
- 133
- -6
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 3.99x
- 1.06x
- Revenue Growth %
- 12.67%
- Operating Profit Growth %
- 42.54%
- Net Profit Growth %
- 196.03%
- 121.15%
- P/E (x)
- 16.24x
- P/B (x)
- 1.66x
- Dividend Yield %
- 0.14%
- 8.19x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-07 - HALEOS LABS LIMITED has informed the Exchange about Copy of Newspaper Publication
- Updates
2026-08-05 - HALEOS LABS LIMITED has informed the Exchange regarding 'Update (Material Subsidiary)'.
Annual Reports
Credit Ratings
- Credit Rating
2026-05-22 - HALEOS LABS LIMITED has informed the Exchange about Credit Rating
Concalls
Jul 2025